SCHEMBL4035604

SCHEMBL4035604

NC(=O)Oc1[nH]c2ccncc2c1Sc1cccc(F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.40
CDC7 O00311 2/20 0.36
TYMS P04818 1/20 0.36
JAK2 O60674 1/20 0.36
HAO1 Q9UJM8 1/20 0.35
ROCK2 O75116 2/20 0.34
CHUK O15111 1/20 0.34
KDM4C Q9H3R0 4/20 0.33
MAPT P10636 2/20 0.33
MAPK14 Q16539 1/20 0.33
EPHX1 P07099 1/20 0.33
TUBB4A P04350 2/20 0.33
TUBB P07437 2/20 0.33
TUBA3C P0DPH7 2/20 0.33
TUBA1B P68363 2/20 0.33
TUBA4A P68366 2/20 0.33
TUBB4B P68371 2/20 0.33
TUBB3 Q13509 2/20 0.33
TUBB2A Q13885 2/20 0.33
TUBB8 Q3ZCM7 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4043016 0.92 ROCK2 (0.40) CDC7TYMSHAO1ROCK2CHUK
SCHEMBL4040089 0.87 TUBB4A (0.41) ACHEJAK2CHUKMAPTTUBB4A
SCHEMBL3839280 0.85 TUBB4A (0.44) TYMSMAPTEPHX1TUBB4ATUBB
SCHEMBL4042268 0.80 ICAM1 (0.36) CHUK
SCHEMBL4035517 0.80 TYMS (0.37) CDC7TYMSJAK2HAO1MAPK14
SCHEMBL4035359 0.79 CSNK2A2 (0.42) TYMSROCK2CHUKTUBB4ATUBB
SCHEMBL4038757 0.78 MAP2 (0.46) ROCK2CHUKMAPTTUBB4ATUBB
SCHEMBL4042867 0.77 TUBB4A (0.46) CDC7JAK2ROCK2CHUKTUBB4A
SCHEMBL1827677 0.77 POLB (0.42) TYMSTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL3269989 0.76 KDR (0.39) TYMSHAO1MAPTEPHX1TUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1747220-B1 SUBSTITUTED 1H-PYRROLO[3,2-B, 3,2-C, AND 2,3-C]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I EPSILON AVENTIS PHARMA INC (US) 2009-04-15 EP claimed